Clinical Trials Browser

Phase 1 × Endometrial Neoplasms × budigalimab × Clear all

NCT03138408 2019-05-14

SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers

Phase 1 Terminated

Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms